SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Inovio Pharmaceuticals Exec Says The Ex-US Trial For COVID-19 Vaccine Candidate Is Not Impacted By The Current Phase 3 Partial Clinical Hold; Says On Track To Submit All Documents To FDA To Uplift The Clinical Hold

- Reuters

05/10/2021 17:15